|
|
||||||||
Ann Thorac Surg 2002;74:2177-2179
© 2002 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Harper University Hospital, Wayne State University, Detroit, Michigan, USA
b Department of Pharmacy, Harper University Hospital, Wayne State University, Detroit, Michigan, USA
c Department of Cardiology, Harper University Hospital, Wayne State University, Detroit, Michigan, USA
Accepted for publication July 10, 2002.
* Address reprint requests to Dr Baciewicz, Department of Cardiothoracic Surgery, Harper University Hospital, 3990 John R, Suite 2101, Detroit, MI 48201, USA.
e-mail: fbaciewi{at}dmc.org
Heparin is the standard agent used for systemic anticoagulation during cardiopulmonary bypass in cardiac operations. Alternatives are needed when patients with heparin-induced thrombocytopenia type II are encountered. We present a patient with a clinical picture of heparin-induced thrombocytopenia type II who was effectively anticoagulated with bivalirudin, a direct thrombin inhibitor, during cardiopulmonary bypass for a cardiac operation.
This article has been cited by other articles:
![]() |
C Collins and A O'Donnell Does an allergy to fish pre-empt an adverse protamine reaction? A case report and a literature review Perfusion, November 1, 2008; 23(6): 369 - 372. [Abstract] [PDF] |
||||
![]() |
T. E. Warkentin, A. Greinacher, A. Koster, and A. M. Lincoff Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 340S - 380S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hassell The Management of Patients With Heparin-Induced Thrombocytopenia Who Require Anticoagulant Therapy Chest, February 1, 2005; 127(2_suppl): 1S - 8S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Matthai Jr Thrombocytopenia in Cardiovascular Patients: Diagnosis and Management Chest, February 1, 2005; 127(2_suppl): 46S - 52S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Gurbuz, W. G. Elliott, and A. A. Zia Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 138 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Clayton, J. R. Acsell, A. J. Crumbley III, A. G. Shackelford, and W. E. Uber Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia Ann. Thorac. Surg., December 1, 2004; 78(6): 2167 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Warkentin and A. Greinacher Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 311S - 337S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Merry, P. J. Raudkivi, N. G. Middleton, J. M. McDougall, P. Nand, B. P. Mills, B. J. Webber, C. M. Frampton, and H. D. White Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery Ann. Thorac. Surg., March 1, 2004; 77(3): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Warkentin and A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann. Thorac. Surg., December 1, 2003; 76(6): 2121 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carrier Reply to the Editor: J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2109 - 2109. [Full Text] [PDF] |
||||
![]() |
F. A. Baciewicz Jr Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2108 - 2109. [Full Text] [PDF] |
||||
![]() |
T. E. Warkentin and A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann. Thorac. Surg., August 1, 2003; 76(2): 638 - 648. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |